Compare AVAH & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | STAA |
|---|---|---|
| Founded | 1984 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Ophthalmic Goods |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 2021 | 1995 |
| Metric | AVAH | STAA |
|---|---|---|
| Price | $7.10 | $28.56 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 9 |
| Target Price | $9.75 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 1.6M | 721.6K |
| Earning Date | 05-14-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1850.00 | N/A |
| EPS | ★ 0.19 | 0.10 |
| Revenue | ★ $2,433,199,000.00 | $239,442,000.00 |
| Revenue This Year | $7.31 | $30.82 |
| Revenue Next Year | $5.59 | $8.41 |
| P/E Ratio | ★ $37.32 | $283.70 |
| Revenue Growth | ★ 20.19 | N/A |
| 52 Week Low | $3.73 | $15.59 |
| 52 Week High | $10.32 | $35.87 |
| Indicator | AVAH | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 53.59 | 46.51 |
| Support Level | $6.22 | $28.03 |
| Resistance Level | $7.52 | $31.05 |
| Average True Range (ATR) | 0.37 | 1.20 |
| MACD | -0.00 | -0.44 |
| Stochastic Oscillator | 59.07 | 9.49 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.